Aug. 1, 2023
- Qurgen had officially engaged with the following 5 hospitals for the Phase I clinical trial of SON-DP in US for the treatment of solid tumors with the focus on breast, ovarian, pancreatic, and colorectal cancers: MD Anderson Cancer Center, Henry Ford Health System, Carolina BioOncology Institute (CBI), Banner MD Anderson at Banner Gateway Medical Center, Stephenson Cancer Center, University of Oklahoma.